Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein. 1998

K A Rye, and M Jauhiainen, and P J Barter, and C Ehnholm
Division of Cardiovascular Services, Royal Adelaide Hospital, South Australia.

Phospholipid transfer protein (PLTP) converts high density lipoproteins (HDL) to larger and smaller particles during incubation in vitro. The present study shows that these conversions are enhanced in triglyceride (TG)-enriched HDL. When pig HDL were enriched with TG by incubation with cholesteryl ester transfer protein (CETP) and very low density lipoproteins, the TG/apoA-I molar ratio increased from 0.7/1 to 11.4/1 and the diameter increased from 9.0 to 9.5 nm. When unmodified pig HDL were incubated with PLTP, the diameter increased from 9.0 to 9.5 nm. Incubation of the TG-enriched pig HDL with PLTP generated larger (13.0 nm) and smaller (7.5 nm) particles. The composition of the large particles was comparable to the non-incubated, TG-enriched HDL. The small particles contained only phospholipids and apolipoprotein (apo) A-I. Studies were also carried out with spherical, reconstituted HDL (rHDL) containing only cholesteryl esters in their core. When the rHDL were enriched with TG by incubation with Intralipid and CETP, the diameter increased from 9.0 to 9.2 nm and the TG/apoA-I molar ratio became 5.7/1. When unmodified rHDL were incubated with PLTP, the diameter of 15% of the particles increased to 11.0 nm, 18% decreased to 7.6 nm, and 67% were unchanged. When the TG-enriched rHDL were incubated with PLTP, the diameter of 62% of the particles increased to 11.4 nm, 26% decreased to 7.6 nm, and 12% did not change. Preincubation with Intralipid alone or CETP alone did not enrich the rHDL with TG or enhance the size changes. These results show that the TG content of HDL has a major influence on PLTP-mediated size changes.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog

Related Publications

K A Rye, and M Jauhiainen, and P J Barter, and C Ehnholm
January 2008, Journal of lipid research,
K A Rye, and M Jauhiainen, and P J Barter, and C Ehnholm
April 2001, Bulletin of experimental biology and medicine,
K A Rye, and M Jauhiainen, and P J Barter, and C Ehnholm
August 1999, Atherosclerosis,
K A Rye, and M Jauhiainen, and P J Barter, and C Ehnholm
July 1999, Biochimica et biophysica acta,
K A Rye, and M Jauhiainen, and P J Barter, and C Ehnholm
June 1996, Biochimica et biophysica acta,
Copied contents to your clipboard!